JP2010202609A - Sheet for pasting to body contained in container - Google Patents

Sheet for pasting to body contained in container Download PDF

Info

Publication number
JP2010202609A
JP2010202609A JP2009051784A JP2009051784A JP2010202609A JP 2010202609 A JP2010202609 A JP 2010202609A JP 2009051784 A JP2009051784 A JP 2009051784A JP 2009051784 A JP2009051784 A JP 2009051784A JP 2010202609 A JP2010202609 A JP 2010202609A
Authority
JP
Japan
Prior art keywords
sheet
gas
foamed
container
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009051784A
Other languages
Japanese (ja)
Other versions
JP5396105B2 (en
Inventor
Hideki Mori
秀樹 森
Hideki Yokomichi
秀季 横道
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2009051784A priority Critical patent/JP5396105B2/en
Publication of JP2010202609A publication Critical patent/JP2010202609A/en
Application granted granted Critical
Publication of JP5396105B2 publication Critical patent/JP5396105B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a drug formulation which can be manufactured in simple way and at a low cost, and which can continuously feed a gas which has physiological activity to a body in a sufficient quantity to the skin. <P>SOLUTION: The sheet for body pasting contained in a container comprises: sealing a sheet of a laminate of a foaming gel layer or a foaming liquid layer containing a gas bubble with 5-50% of a bubble ratio, and a resin film in a hardly gas-permeable container; and containing at least 30 mass% of a gas which has the physiological activity to a body in a gap part in the container at the time of preservation. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は、身体に対して生理活性のある気体を、身体に貼付することにより皮膚に供給するための発泡シート剤に関する。   The present invention relates to a foam sheet for supplying a gas having physiological activity to the body by applying it to the skin.

酸素や二酸化炭素等の気体は、有効成分として各種の生理作用を有することが知られている。例えば、酸素には、抗菌作用、創傷治癒、皮膚ケラチノサイト増殖、コラーゲン産生等の生理作用が、また二酸化炭素には血行促進効果があることが知られている。これらを有効成分として皮膚に供給する形態としては、塗布剤として製剤中に溶解・分散させる、またシート剤として貼付する等の方法があり、目的に応じて使い分けられている。シート剤は、貼付けた状態を保てることから簡便に、かつ持続的な有効成分の皮膚への供給ができる。しかしながら、気体を高濃度に維持することは困難であり、その手段としては、例えば、製剤中に溶解や分散した2種の乾燥試薬をそれぞれ可撓性多孔層に保持させ、使用時に酸素を発生させるフィルム(特許文献1)、層相互間に高レベルの酸素をあらかじめ気体で充填して皮膚に供給する酸素包帯(特許文献2)、過酸化水素及び/又は酸素が過酸化水素及び疎水化した二酸化ケイ素を含有する粉体状混合物から放出される技術(特許文献3)等が報告されている。しかし、このようにフィルムや包帯等のシート状物によって、気体状態で皮膚に供給される有効成分濃度は、通常の空気から供給される濃度とほとんど変わらず、十分な効果は得られない。   Gases such as oxygen and carbon dioxide are known to have various physiological actions as active ingredients. For example, oxygen is known to have physiological effects such as antibacterial action, wound healing, skin keratinocyte proliferation, collagen production, and carbon dioxide has blood circulation promoting effects. As a form for supplying these to the skin as an active ingredient, there are methods such as dissolving and dispersing in the preparation as an application agent, and sticking as a sheet agent, and they are properly used depending on the purpose. Since the sheet agent can be kept in the pasted state, the active ingredient can be easily and continuously supplied to the skin. However, it is difficult to maintain a high concentration of gas. For example, two dry reagents dissolved or dispersed in the preparation are held in the flexible porous layer to generate oxygen during use. Film (Patent Document 1), oxygen bandage (Patent Document 2) for supplying the skin with a high level of oxygen in advance between layers, hydrogen peroxide and / or oxygen is hydrophobized and hydrophobized A technique (Patent Document 3) released from a powdery mixture containing silicon dioxide has been reported. However, the active ingredient concentration supplied to the skin in a gaseous state by the sheet-like material such as a film or a bandage is almost the same as the concentration supplied from normal air, and a sufficient effect cannot be obtained.

また、血行促進効果を得る目的で、二酸化炭素を皮膚に供給しようとする技術も知られている。例えば、特許文献4には、遊離炭酸を高濃度に含有する手段として、高濃度の二酸化炭素が溶存したゾルをシート材への塗布後にゲル化させて使用する、ゾル−ゲル転移する組成物からなる炭酸経皮吸収用組成物が記載されているが、シートの製造時に二酸化炭素の揮散を防ぐ具体的な手段が示されておらず、実際に二酸化炭素を十分に皮膚に供給することは困難と考えられる。さらに、二酸化炭素の持続性を向上させるため、液又はゲルのpHを3.5〜6.5に調整し、液又はゲル中の二酸化炭素濃度を一定の範囲とし、かつ包装ピロー内の容積とゲル充填比を40%以下としたシート状貼付剤が記載されている(特許文献5)。   In addition, a technique for supplying carbon dioxide to the skin for the purpose of obtaining a blood circulation promoting effect is also known. For example, Patent Document 4 discloses a sol-gel transition composition in which a sol in which a high concentration of carbon dioxide is dissolved is used after being applied to a sheet material as a means for containing a high concentration of free carbonic acid. The carbon dioxide percutaneous absorption composition is described, but there is no specific means for preventing the volatilization of carbon dioxide at the time of manufacturing the sheet, and it is difficult to actually supply carbon dioxide to the skin sufficiently. it is conceivable that. Furthermore, in order to improve the sustainability of carbon dioxide, the pH of the liquid or gel is adjusted to 3.5 to 6.5, the carbon dioxide concentration in the liquid or gel is within a certain range, and the volume in the packaging pillow A sheet-like patch having a gel filling ratio of 40% or less is described (Patent Document 5).

特表平8−510155号公報Japanese translation of PCT publication No. 8-510155 特表2007−524447号公報Special table 2007-524447 特表2007−504089号公報Special table 2007-504089 gazette 特開2003−34612号公報JP 2003-34612 A 特開2005−170937号公報JP 2005-170937 A

しかしながら、これらの技術では皮膚に適用した際の製剤から皮膚への有効成分の供給量が考慮されておらず、シート剤の粘着性や重さによる使用性が十分でなく、さらに高濃度の気体を持続的に皮膚に供給できる技術が望まれている。
従って、本発明の課題は、簡便かつ安価に製造でき、かつ十分な量の身体に対して生理活性のある気体を皮膚に持続的に供給することができる製剤を提供することにある。
However, these technologies do not take into account the amount of active ingredients supplied to the skin from the formulation when applied to the skin, and are not sufficiently usable due to the adhesiveness and weight of the sheet. There is a demand for a technology that can continuously supply the skin to the skin.
Accordingly, an object of the present invention is to provide a preparation that can be easily and inexpensively manufactured and can continuously supply a sufficient amount of a physiologically active gas to the skin.

そこで本発明者は、持続的に皮膚に気体を供給する手段として、液状又はゲル状のシート中に気体を含有させて貼付することを検討した。しかし、シート剤中に皮膚に十分供給できるだけの量の気体成分を高濃度に溶解又は分散させることは困難である。シート剤は水性溶液又は水性ゲル剤を主体とするものが多く、酸素のような溶解性の低い生理活性気体はシート剤への保持量が少ないため、使用時の持続性が十分でなく、結果として皮膚への酸素供給量は十分でないことが判明した。
そこでさらに検討したところ、気泡を保持した発泡ゲル層又は発泡液層に樹脂フィルムを積層してシートとし、これを気体難透過性容器内に封入する際に、容器内の空隙部の酸素濃度を制御することに到達した。それにより、容器中で気泡と身体に対して生理活性のある気体との置換が行なわれ、かつ発泡ゲル層又は発泡液層に該生理活性気体が溶解し、容器から取り出して皮膚に貼付したときにシート中の生理活性気体が効率的に皮膚に供給されるだけでなく、気泡を含むためにシートが軽くフィット性が向上するために、その効果も持続することを見出した。
Therefore, the present inventor has studied that gas is contained in a liquid or gel sheet as a means for continuously supplying gas to the skin. However, it is difficult to dissolve or disperse a gas component in an amount sufficient to supply the skin sufficiently in the sheet. Many of the sheet agents are mainly aqueous solutions or aqueous gel agents, and bioactive gases with low solubility such as oxygen have a small amount of retention in the sheet agent, resulting in insufficient sustainability during use. As it turns out, the oxygen supply to the skin is not enough.
Therefore, when further examination was made, when a resin film was laminated on a foamed gel layer or foamed liquid layer holding bubbles to form a sheet, and this was sealed in a gas-impermeable container, the oxygen concentration in the voids in the container was set. Reached to control. As a result, when the bubble is replaced with a gas that is physiologically active for the body in the container, and the physiologically active gas is dissolved in the foamed gel layer or the foamed liquid layer, taken out of the container and applied to the skin In addition, the present inventors have found that not only the physiologically active gas in the sheet is efficiently supplied to the skin, but also the effect of the sheet is sustained because the sheet is light and the fit property is improved because it contains bubbles.

すなわち、本発明は、気泡率5〜50%の気泡を含有する発泡ゲル層又は発泡液層と樹脂フィルムとの積層シートを気体難透過性容器内に密封してなり、保存時の容器中の空隙部に身体に対して生理活性を有する気体を30質量%以上含有する容器入り身体貼付用シート、及びその製造法を提供するものである。   That is, the present invention comprises a foamed gel layer or foamed liquid layer containing bubbles having a cell ratio of 5 to 50%, and a laminated sheet of a resin film sealed in a gas-impermeable container, It is intended to provide a container-attached sheet for body sticking containing 30% by mass or more of a gas having physiological activity with respect to the body in the void, and a method for producing the same.

本発明の身体貼付用シートは、安価な材料を用いて簡便な操作で製造することができ、かつ単に容器から取り出して身体に貼付するだけで、貼付部位に高濃度の生理活性気体を持続的に供給することができる。従って、皮膚局所において、各種気体の生理活性作用が安全かつ簡便な操作で得られる。さらに、皮膚貼付面が気泡を含有しているので、貼付時のフィット感が良好である。   The sheet for body sticking of the present invention can be manufactured by a simple operation using an inexpensive material, and a high-concentration physiologically active gas can be continuously applied to the sticking site simply by removing it from the container and sticking it to the body. Can be supplied to. Therefore, physiologically active actions of various gases can be obtained in a safe and simple operation in the skin region. Furthermore, since the skin application surface contains air bubbles, the fit at the time of application is good.

本発明シートの形状の一例を示す。An example of the shape of this invention sheet | seat is shown.

本発明の身体貼付用シートは、気泡率5〜50%の気泡を有する発泡ゲル層又は発泡液層と樹脂フィルムとの積層シートが気体難透過性容器内に密封されている。   In the body sticking sheet of the present invention, a foamed gel layer or foamed liquid layer having a bubble rate of 5 to 50% and a laminated sheet of a resin film are sealed in a gas-impermeable container.

積層シートを密封する気体難透過性容器は、容器内部の気体を流出させず、また容器内部の水分や他の揮発成分も流出を防ぐことができること、他方、外部から生理活性気体以外の気体の流入を防ぐ点から気体難透過性である。ここで難透過性とは、気体透過度が50cc/m2・day・atm(ASTM D−1434)以下であることをいうが、非透過性であるのが好ましい。好ましい材料としてはヒートシール性を有するものが好ましく、具体的には、アルミニウム箔を積層したラミネートフィルム、アルミニウム蒸着層を有するラミネートフィルム、ポリ塩化ビニリデンフィルム、ポリ塩化ビニリデン層を含むラミネートフィルムなどが挙げられる。容器の形態は平袋、ガゼットなどが好ましい。 The gas-impermeable container that seals the laminated sheet does not allow the gas inside the container to flow out, and can prevent the moisture and other volatile components inside the container from flowing out. It is gas permeable from the point of preventing inflow. Here, “impermeable” means that the gas permeability is 50 cc / m 2 · day · atm (ASTM D-1434) or less, preferably non-permeable. Preferable materials are those having heat-sealing properties, specifically, a laminate film laminated with an aluminum foil, a laminate film having an aluminum deposited layer, a polyvinylidene chloride film, a laminate film containing a polyvinylidene chloride layer, and the like. It is done. The container is preferably a flat bag or a gusset.

積層シートは、気泡率5〜50%の気泡を含有する発泡ゲル層又は発泡液層と樹脂フィルムとを積層したものである。発泡ゲル層又は発泡液層の形態は、シート状の発泡ゲル層又は発泡液層である。積層シートの厚さは、生理活性気体の保持量および貼付時の使用感の点から、0.1〜5mmであることが好ましく、さらにフィット性の点から0.3〜4mm、特に0.5〜3mmが好ましい。   The laminated sheet is obtained by laminating a foamed gel layer or foamed liquid layer containing bubbles having a cell rate of 5 to 50% and a resin film. The foamed gel layer or foamed liquid layer is a sheet-like foamed gel layer or foamed liquid layer. The thickness of the laminated sheet is preferably 0.1 to 5 mm from the viewpoint of the amount of physiologically active gas retained and the feeling of use at the time of sticking, and further 0.3 to 4 mm, particularly 0.5 from the viewpoint of fit. ~ 3 mm is preferred.

発泡ゲル層又は発泡液層は気泡を含み、その気泡率は、容器中に充填された生理活性気体との置換性及び貼付時の使用感の点から5〜50%であるが、さらに7〜45%、特に10〜40%が好ましい。気泡の大きさは、気体の種類やシート剤の厚さによるが、気体の保持とシート強度や柔軟性、またフィット性や追随性等の使用感の点から0.01〜2mmの範囲であることが好ましく、さらに0.01〜1.5mm、特に0.01〜1mmが好ましい。かかる気泡は、ゲル層又は液層の形成時に攪拌する、化学反応により気体(ガス)を発生させる、また液化ガス等を配合した液を高圧状態から噴射すること等により形成させることができる。特に、気泡の安定性の点から、ゲル層又は液層の形成時に攪拌して気泡を形成した発泡ゲル層が好ましい。ここで、気泡率は、以下のように測定できる。
発泡層が液状であれば、泡をつぶさないように容量既知(AmLとする)の容器に充填して内容物の重量を測定(Bgとする)して、式(1)により計算する。また、発泡層がゲル状であれば直方体形状に切り出し、縦・横・高さから体積を算出(AmLとする)し、また重量を測定(Bgとする)して、同様に式(1)により計算する。なお、気泡を除いた部分の比重を1と仮定する。
The foamed gel layer or the foamed liquid layer contains bubbles, and the bubble ratio is 5 to 50% from the viewpoint of the displaceability with the bioactive gas filled in the container and the feeling of use at the time of application. 45%, particularly 10 to 40% is preferred. The size of the bubble depends on the type of gas and the thickness of the sheet, but is in the range of 0.01 to 2 mm in terms of gas retention, sheet strength and flexibility, and feeling of use such as fit and followability. It is preferably 0.01 to 1.5 mm, more preferably 0.01 to 1 mm. Such bubbles can be formed by stirring during formation of the gel layer or liquid layer, generating a gas (gas) by a chemical reaction, or injecting a liquid containing a liquefied gas from a high pressure state. In particular, from the viewpoint of the stability of the bubbles, a foamed gel layer in which bubbles are formed by stirring when forming the gel layer or the liquid layer is preferable. Here, the bubble ratio can be measured as follows.
If the foamed layer is liquid, it is filled in a container of known capacity (AmL) so as not to crush the foam, the weight of the content is measured (Bg), and the calculation is performed according to the equation (1). If the foam layer is gel, cut into a rectangular parallelepiped shape, calculate the volume from the length, width and height (AmL), measure the weight (Bg), and similarly formula (1) Calculate according to It is assumed that the specific gravity of the portion excluding the bubbles is 1.

(数1)
気泡率(%)=(A−B)/A×100 式(1)
(Equation 1)
Bubble ratio (%) = (A−B) / A × 100 Formula (1)

また気泡の大きさは、顕微鏡観察によって測定できる。   The bubble size can be measured by microscopic observation.

当該発泡ゲル層又は発泡液層は、発泡水溶液、発泡水性ゲル、油相を含む発泡乳液状または発泡乳化ゲル状組成物、発泡油層、油性発泡ゲルのいずれの形態でもよい。ここで油相又は油層を形成する油分としては、生理活性気体溶存量を向上させる点、皮膚に対する安全性、使用後の保湿感の点から、長鎖炭化水素、高級脂肪酸、高級脂肪酸エステル、高級アルコール、シリコーン類、フルオロカーボン類等が挙げられる。長鎖炭化水素としては液状(25℃)であることが好ましく、流動パラフィン、スクワラン、スクワレン等が挙げられ、特に流動パラフィンが好ましい。また、高級脂肪酸、高級脂肪酸エステル、高級アルコールでは、特に分岐脂肪酸、不飽和脂肪酸、分岐脂肪酸エステル、不飽和脂肪酸エステル、分岐脂肪族アルコール、不飽和脂肪族アルコールが液状を呈することから好ましく、例えば、ホホバ油、オリーブ油、ヒマシ油、ミンク油、マカデミアンナッツ油等の天然油脂類や、ミリスチン酸イソプロピル、ジイソステアリン酸ジグリセリルなど不飽和脂肪酸や分岐脂肪酸のエステルなどが好ましい。シリコーン類としては、ジメチルステアリルポリシロキサン等のアルキル変性シリコーン、高重合メチルポリシロキサン、架橋型メチルポリシロキサン、フッ素化されたフルオロシリコーン等が好ましい。さらにフルオロカーボン類としては、2−(パーフルオロヘキシル)エチル1,3−ジメチルブチルエーテル等のパーフルオロポリエーテル、ハイドロフルオロエーテル等が使用できる。これらの油分は、油相又は油層を形成した状態で発泡ゲル層又は発泡液層に存在することが好ましく、発泡ゲル層又は発泡液層中に0.1〜35質量%、さらに0.5〜20質量%、特に0.5〜15質量%含有させるのが好ましい。   The foamed gel layer or foamed liquid layer may be in any form of foamed aqueous solution, foamed aqueous gel, foamed emulsion or foamed emulsified gel-like composition containing an oil phase, foamed oil layer, and oily foamed gel. Here, the oil component that forms the oil phase or oil layer includes long chain hydrocarbons, higher fatty acids, higher fatty acid esters, higher fatty acids from the viewpoint of improving the amount of bioactive gas dissolved, safety to the skin, and moisturizing feeling after use. Alcohols, silicones, fluorocarbons and the like can be mentioned. The long-chain hydrocarbon is preferably liquid (25 ° C.), and examples thereof include liquid paraffin, squalane, squalene and the like, and liquid paraffin is particularly preferable. In addition, higher fatty acids, higher fatty acid esters, and higher alcohols are particularly preferred because branched fatty acids, unsaturated fatty acids, branched fatty acid esters, unsaturated fatty acid esters, branched fatty alcohols, unsaturated aliphatic alcohols are liquid, for example, Preferred are natural fats and oils such as jojoba oil, olive oil, castor oil, mink oil and macadamian nut oil, and unsaturated fatty acids such as isopropyl myristate and diglyceryl diisostearate, and esters of branched fatty acids. As silicones, alkyl-modified silicone such as dimethylstearyl polysiloxane, highly polymerized methyl polysiloxane, cross-linked methyl polysiloxane, fluorinated fluorosilicone, and the like are preferable. Furthermore, as fluorocarbons, perfluoropolyethers such as 2- (perfluorohexyl) ethyl 1,3-dimethylbutyl ether, hydrofluoroethers, and the like can be used. These oil components are preferably present in the foamed gel layer or the foamed liquid layer in a state where an oil phase or an oil layer is formed, and 0.1 to 35% by mass in the foamed gel layer or the foamed liquid layer, and further 0.5 to It is preferable to make it contain 20 mass%, especially 0.5-15 mass%.

また、発泡ゲル層又は発泡液層には、発泡性の向上、上記油分や植物エキスなどの分散、また肌への付着性を改良する為に、各種乳化剤を配合できる。例えば、グリセリンモノ脂肪酸エステル、ポリグリセリンモノ脂肪酸エステル、ソルビタンモノ脂肪酸エステル、ポリエチレングリコールモノ脂肪酸エステル、ポリオキシエチレンソルビタンモノ脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンアルキルエーテルなどの非イオン性界面活性剤;炭素数12〜18の直鎖又は分岐脂肪酸塩、炭素数12〜18のアルキルリン酸エステル塩、N−アシルアミノ酸塩などのアニオン性界面活性剤;塩化ステアリルトリメチルアンモニウム、塩化ジステアリルジメチルアンモニウムなどのカチオン性界面活性剤を挙げることができる。   Moreover, various emulsifiers can be blended in the foamed gel layer or the foamed liquid layer in order to improve foamability, disperse the oil and plant extract, and improve adhesion to the skin. Nonionic interfaces such as glycerin monofatty acid ester, polyglycerin monofatty acid ester, sorbitan monofatty acid ester, polyethylene glycol monofatty acid ester, polyoxyethylene sorbitan monofatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether Activating agents; anionic surfactants such as linear or branched fatty acid salts having 12 to 18 carbon atoms, alkyl phosphoric acid ester salts having 12 to 18 carbon atoms, N-acyl amino acid salts; stearyltrimethylammonium chloride, distearyldimethyl chloride Mention may be made of cationic surfactants such as ammonium.

発泡ゲル層又は発泡液層には植物エキスを配合することができる。植物エキスとしては、例えば甘草エキス、グリチルリチン酸及びその誘導体、グリチルレチン酸及びその誘導体、脂溶性グリチルレチン酸類、アズレン、グアイアズレン、オウゴンエキス、カミツレエキス、クマザサエキス、シラカバエキス、ゼニアオイエキス、桃葉エキス、セイヨウノコギリソウエキス、キキョウエキス、ビワ葉エキス、ボダイジュエキス、ユーカリエキスなどの抗炎症作用をもつもの;ショウキョウエキス、オランダカラシ、カンタリスチンキ、サンショウエキス、ハッカ油、ワサビ大根エキスなどの局所刺激作用をもつもの;ルチン誘導体や、ヒバマタエキス、セージ抽出物など、はりやむくみに効果のあるものなどが挙げられる。また、植物エキス以外の抗生物質、抗真菌剤、抗炎症剤、血行促進剤、ビタミン類、保湿剤なども配合することができる。さらに、鉱物性粉体、例えばカオリン、スクメタイト、酸化亜鉛、酸化チタンなども配合できる。   A plant extract can be mix | blended with a foaming gel layer or a foaming liquid layer. Plant extracts include, for example, licorice extract, glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, fat-soluble glycyrrhetinic acids, azulene, guaiazulene, oxon extract, chamomile extract, white birch extract, zebra oyster extract, peach leaf extract, yarrow Anti-inflammatory effects such as extract, kyoto extract, loquat leaf extract, body sage extract, eucalyptus extract; What is possessed; Rutin derivatives, Hibamata extract, sage extract, and the like, which are effective for ablation and swelling. Antibiotics other than plant extracts, antifungal agents, anti-inflammatory agents, blood circulation promoters, vitamins, humectants, and the like can also be added. Furthermore, mineral powders such as kaolin, sukumite, zinc oxide, titanium oxide and the like can be blended.

発泡ゲル層を形成するにあたっては、水溶性高分子、多価アルコール等を用いることができる。ここで水溶性高分子として、例えば、ポリアクリル酸類、ポリメタアクリル酸類、ポリアクリルアミド、ポリビニルアルコール、ポリビニルピロリドン、アルギン酸塩、ペクチン等のアニオン性ポリマーと多価陽イオンからなるゲル;カルボキシメチルセルロースなどのセルロース、セルロース誘導体又はその塩類、キサンタンガム、ゼラチン、プルラン、寒天、アラビアゴム、キトサン及びその誘導体など水溶性高分子及び水を使用した含水ゲルなどが挙げられる。このうち、アニオン性ポリマーと多価陽イオンにより形成された発泡水性ゲル層が好ましい。これらの水溶性高分子は1種又は2種以上用いることができ、発泡ゲル層中に0.5〜30質量%、さらに0.5〜20質量%、特に0.5〜15質量%含有するのが好ましい。多価陽イオンとしてはアルミニウムイオン等の多価金属イオンが挙げられる。   In forming the foamed gel layer, a water-soluble polymer, a polyhydric alcohol, or the like can be used. Examples of water-soluble polymers include polyacrylic acids, polymethacrylic acids, polyacrylamide, polyvinyl alcohol, polyvinyl pyrrolidone, alginates, gels composed of polyvalent cations such as pectin and the like; carboxymethyl cellulose and the like Examples thereof include cellulose, cellulose derivatives or salts thereof, xanthan gum, gelatin, pullulan, agar, gum arabic, chitosan and water-containing gels using water, such as chitosan and derivatives thereof. Of these, a foamed aqueous gel layer formed of an anionic polymer and a polyvalent cation is preferred. These water-soluble polymers can be used singly or in combination of 0.5 to 30% by weight, more preferably 0.5 to 20% by weight, particularly 0.5 to 15% by weight in the foamed gel layer. Is preferred. Examples of the polyvalent cation include polyvalent metal ions such as aluminum ions.

多価アルコールとしては、グリセリン、ポリグリセリン、プロピレングリコール、ポリエチレングリコール、1,3−ブタンジオール、ソルビトール、キシリトールなどが挙げられる。これらの多価アルコールは1種又は2種以上用いることができ、ゲル中に3〜60質量%、さらに3〜50質量%、特に5〜40質量%含有するのが好ましい。また、付着性を調節する目的で、これらポリオール以外に、ワセリン、デキストリンなども使用できる。   Examples of the polyhydric alcohol include glycerin, polyglycerin, propylene glycol, polyethylene glycol, 1,3-butanediol, sorbitol, and xylitol. These polyhydric alcohols can be used singly or in combination of 3 to 60% by mass, more preferably 3 to 50% by mass, and particularly preferably 5 to 40% by mass in the gel. In addition to these polyols, petrolatum, dextrin and the like can also be used for the purpose of adjusting adhesion.

発泡液層は、例えば、不織布に水性溶液を含浸させて発泡させたものを用いることができる。   As the foaming liquid layer, for example, a nonwoven fabric impregnated with an aqueous solution and foamed can be used.

発泡ゲル層又は発泡液層には樹脂フィルムが積層されている。樹脂フィルムの積層により、身体貼付時の発泡ゲル層又は発泡液層からの水分蒸散が抑制されてシートが乾燥するのを防ぐことができる。また、積層シートを容器に入れ、次いで容器中に生理活性気体を充填して容器を密封することにより、容器中に充填された生理活性気体が発泡ゲル層又は発泡液層の気泡と置換し、かつ直接溶解するとともに、樹脂フィルム側からも生理活性気体が透過して発泡ゲル層又は発泡液層中へ徐々に溶解する。一方、シートを容器から取り出して、樹脂フィルムの反対側、すなわち発泡ゲル層又は発泡液層側を身体に貼付することにより、フィルム側からの生理活性気体の流出は抑制されるので、皮膚への生理活性気体供給量及び持続時間が向上する。かかる観点から、樹脂フィルムの気体透過性は低いことが必要であり、20000cc/m2・day・atm(25℃)以下が好ましく、さらに15000cc/m2・day・atm(25℃)以下がより好ましく、0.001〜13000cc/m2・day・atm(25℃)が特に好ましい。さらに、発泡ゲル層又は発泡液層が厚い場合には、生理活性気体はシートの外周縁からも溶解するため、実質的に酸素透過性がなくてもよい。なお、樹脂フィルムの気体透過性は、ASTM D−1434に基づき測定した値である。 A resin film is laminated on the foamed gel layer or the foamed liquid layer. By laminating the resin film, moisture evaporation from the foamed gel layer or the foamed liquid layer at the time of body sticking can be suppressed and the sheet can be prevented from drying. Further, by putting the laminated sheet into a container, and then filling the container with a bioactive gas and sealing the container, the bioactive gas filled in the container is replaced with bubbles in the foamed gel layer or the foamed liquid layer, And while melt | dissolving directly, bioactive gas permeate | transmits also from the resin film side, and melt | dissolves gradually in a foaming gel layer or a foaming liquid layer. On the other hand, by removing the sheet from the container and sticking the opposite side of the resin film, that is, the foamed gel layer or the foamed liquid layer side to the body, the outflow of the bioactive gas from the film side is suppressed. Physiologically active gas supply amount and duration are improved. From this viewpoint, the gas permeability of the resin film needs to be low, preferably 20000 cc / m 2 · day · atm (25 ° C) or less, and more preferably 15000 cc / m 2 · day · atm (25 ° C) or less. 0.001 to 13000 cc / m 2 · day · atm (25 ° C.) is particularly preferable. Furthermore, when the foamed gel layer or the foamed liquid layer is thick, the physiologically active gas is dissolved from the outer peripheral edge of the sheet, so that it does not have to be substantially oxygen permeable. In addition, the gas permeability of a resin film is the value measured based on ASTM D-1434.

生理活性気体(身体に対して生理活性を有する気体)としては、酸素、二酸化炭素、水素、亜酸化窒素、一酸化炭素等が挙げられるが、酸素及び二酸化炭素が好ましい。   Examples of the physiologically active gas (gas having physiological activity for the body) include oxygen, carbon dioxide, hydrogen, nitrous oxide, carbon monoxide, and the like, and oxygen and carbon dioxide are preferable.

フィルムの材質としては、例えば、ポリエチレン(PE)、ポリプロピレン(PP)、軟質塩化ビニル、ポリエステル、ナイロン、ポリウレタン、エチレン/ビニルアルコール共重合体、エチレン/酢酸ビニル共重合体などのフィルムが使用できる。また、ナイロンフィルムやエチレンビニルアルコール共重合体(EVOH)をポリエチレンやポリプロピレンフィルムなどで挟み込んだ多層フィルムなども使用できる。さらに、これらフィルムにアルミニウム蒸着させたものやガラス蒸着させたフィルムや、さらにこれらをラミネートしたフィルムも使用できる。
フィルムの厚さは、感触の面からなるべく薄いものが好ましく、100μm以下が好ましく、特に50μm以下が好ましい。また、積層時のシール条件により破れない為に、5μm以上のものが好ましい。
Examples of the film material include polyethylene (PE), polypropylene (PP), soft vinyl chloride, polyester, nylon, polyurethane, ethylene / vinyl alcohol copolymer, ethylene / vinyl acetate copolymer, and the like. In addition, a multilayer film in which a nylon film or an ethylene vinyl alcohol copolymer (EVOH) is sandwiched between polyethylene or polypropylene films can also be used. Further, a film in which aluminum is vapor-deposited on these films, a film in which glass is vapor-deposited, or a film obtained by laminating these films can also be used.
The thickness of the film is preferably as thin as possible in terms of touch, preferably 100 μm or less, and particularly preferably 50 μm or less. Moreover, in order not to be broken by the sealing conditions at the time of lamination, those of 5 μm or more are preferable.

より好ましいフィルムと発泡ゲル層又は発泡液層との積層手段は、フィルムに予め不織布を積層しておき、これに発泡液を含浸させるか又は含浸した発泡液層をゲル化させるのが好ましい。フィルムと不織布の積層方法は、接着剤や熱融着、Tダイ押出ラミネートなどの方法を採用することができる。薄いフィルムを積層する場合、例えば接着剤を用いるか、もしくは耐熱性の高いナイロンを熱融着性の高いポリエチレンフィルムで挟み込んだ多層フィルムを使用することで、積層時に微細な破れ穴あきなどが起きないように熱融着することができる。   More preferably, the means for laminating the film and the foamed gel layer or the foamed liquid layer is such that a nonwoven fabric is laminated on the film in advance, and the foamed liquid is impregnated into the film or the impregnated foamed liquid layer is gelled. As a method for laminating the film and the nonwoven fabric, methods such as an adhesive, heat fusion, and T-die extrusion lamination can be employed. When laminating thin films, for example, by using an adhesive or using a multilayer film in which nylon with high heat resistance is sandwiched between polyethylene films with high heat-fusibility, fine tear holes are generated during lamination. So that it can be heat-sealed.

積層シートは、生理活性気体とともに容器内に密封することにより、積層シートの発泡ゲル層又は発泡液層内に生理活性気体を溶存させ、かつ生理活性気体を溶存した状態で維持することができる。このとき、生理活性気体は、容器内の空隙部気体中の30質量%以上、好ましくは50質量%以上、特に好ましくは70質量%以上で充填することにより、前記発泡ゲル層又は発泡液層中の溶存生理活性気体濃度を維持することができる。容器内の生理活性気体以外のガスとしては、例えば窒素ガス等を含むことができる。
ここで、生理活性気体が酸素の場合、空隙部気体中の酸素濃度は、食品用微量酸素分析計IS−300(飯島電子工業(株)製)を用いて測定する。気体の酸素濃度が25%以下の場合には、測定器の使用方法に従い通常の手順で行う。また、酸素濃度が25%以上の場合には、被検気体(酸素)と酸素以外の生理活性を持たない気体(例えば、窒素ガス)を1:4で混合して測定し、以下の式で算出した。
The laminated sheet is sealed in a container together with the physiologically active gas, so that the physiologically active gas is dissolved in the foamed gel layer or the foamed liquid layer of the laminated sheet and can be maintained in a state where the physiologically active gas is dissolved. At this time, the physiologically active gas is filled in the foamed gel layer or the foamed liquid layer by filling 30% by mass or more, preferably 50% by mass or more, particularly preferably 70% by mass or more in the void gas in the container. The concentration of dissolved bioactive gas can be maintained. Examples of the gas other than the physiologically active gas in the container may include nitrogen gas.
Here, when the physiologically active gas is oxygen, the oxygen concentration in the void gas is measured using a food-use trace oxygen analyzer IS-300 (manufactured by Iijima Electronics Co., Ltd.). When the oxygen concentration of the gas is 25% or less, the normal procedure is followed according to the method of using the measuring instrument. When the oxygen concentration is 25% or more, measurement is performed by mixing a test gas (oxygen) and a gas having no physiological activity other than oxygen (for example, nitrogen gas) at a ratio of 1: 4. Calculated.

(数2)
空隙部酸素濃度(%)=測定値(%)×5
(Equation 2)
Void oxygen concentration (%) = measured value (%) × 5

また、生理活性気体が酸素以外の場合(例えば、二酸化炭素等)には、上述の食品用微量酸素分析計IS−300を用いて空隙部気体中の酸素の濃度を測定し、その測定値から下記式により簡易的に計算できる。   In addition, when the physiologically active gas is other than oxygen (for example, carbon dioxide), the concentration of oxygen in the void gas is measured using the above-described trace oxygen analyzer for food IS-300, and the measured value is used. It can be easily calculated by the following formula.

(数3)
空隙部生理活性気体濃度(%)=(20.6−測定値(%))/20.6×100
(Equation 3)
Void bioactive gas concentration (%) = (20.6−measured value (%)) / 20.6 × 100

ここで、「20.6」は空気中の酸素濃度を示し、容器内空隙部の当該気体以外の成分は、空気と同じ比率と仮定した。   Here, “20.6” indicates the oxygen concentration in the air, and the components other than the gas in the void in the container are assumed to have the same ratio as air.

包装ピロー内に充填されたガスの圧力(保存時の容器内部圧)は25℃において、0.05〜0.15MPa、さらに0.08〜0.15MPa、特に0.09〜0.12MPaが好ましい。   The pressure of the gas filled in the packaging pillow (the container internal pressure during storage) is preferably 0.05 to 0.15 MPa, more preferably 0.08 to 0.15 MPa, and particularly preferably 0.09 to 0.12 MPa at 25 ° C. .

本発明の容器入りシートは、例えば前記積層シートを容器内に入れ、次いで容器内のガスを生理活性気体30質量%以上の気体に交換する方法により製造できる。このように、常圧下で容器内のガスを生理活性気体に交換して、シートに生理活性気体を溶存させる方法を採用すると、高濃度生理活性気体溶存ゲル又は液を調整する調整槽や、生理活性気体が漏れない状態にて容器に充填する設備が不要となるメリットがある。特に好ましい形態としては、容器内に25℃で発泡ゲル又は発泡液のシートを充填し、これに適量の生理活性気体を封入する方法が、製造・流通上の体積を低減でき、かつ発泡ゲル又は発泡液に生理活性気体を飽和溶解させる上からも好ましい。勿論、生理活性気体を容器内に充填する際に、常圧でなく加圧で行なっても良い。なお、生理活性気体は一般的に水性ゲルや溶液に対する溶解性が低いため、生理活性気体で置換又は充填する製造工程であっても、包装容器に充填した後に発泡ゲル層又は発泡液層に溶存されて空隙から減少する量はわずかである。包装容器へ直接充填する際には、発泡ゲル層又は発泡液層に溶存する量を計算し、上記空隙中の生理活性気体量に加算した量を充填することが好ましい。例えば、発泡ゲル層又は発泡液層を含む積層シートを容器内に入れた後に容器内のガスを100%濃度酸素で置換した場合、液又はゲルに溶解する酸素の量は、液又はゲル1gに対しておよそ0.03mLになる。また、油剤は一般に水に比べて3〜10倍程度酸素の溶解度が高いため、発泡ゲル又は発泡液に油剤を含有させた場合は、その配合量に応じて酸素を多めに充填することが好ましい。   The container-containing sheet of the present invention can be produced, for example, by a method in which the laminated sheet is placed in a container and the gas in the container is then exchanged with a gas having a physiologically active gas of 30% by mass or more. Thus, by adopting a method in which the gas in the container is exchanged with a physiologically active gas under normal pressure and the physiologically active gas is dissolved in the sheet, an adjustment tank for adjusting a highly concentrated physiologically active gas dissolved gel or liquid, There is an advantage that the facility for filling the container in a state where the active gas does not leak becomes unnecessary. As a particularly preferred form, a method of filling a container with a foamed gel or foamed liquid sheet at 25 ° C. and enclosing an appropriate amount of a physiologically active gas can reduce the volume in production and distribution, and the foamed gel or It is also preferable from the viewpoint of saturated dissolution of the physiologically active gas in the foaming liquid. Of course, when filling the physiologically active gas into the container, it may be performed not under normal pressure but under pressure. Since bioactive gases generally have low solubility in aqueous gels and solutions, they are dissolved in the foamed gel layer or foamed liquid layer after filling the packaging container even in the manufacturing process where the bioactive gas is replaced or filled. The amount that is reduced from the void is small. When directly filling the packaging container, it is preferable to calculate the amount dissolved in the foamed gel layer or the foamed liquid layer and fill the amount added to the amount of the physiologically active gas in the void. For example, when a laminated sheet containing a foamed gel layer or a foamed liquid layer is placed in a container and the gas in the container is replaced with 100% concentration oxygen, the amount of oxygen dissolved in the liquid or gel is 1 g of the liquid or gel. In contrast, it becomes approximately 0.03 mL. Moreover, since the oil agent generally has a solubility of oxygen that is about 3 to 10 times higher than that of water, when the oil agent is contained in the foamed gel or the foaming liquid, it is preferable to fill the oxygen in a larger amount depending on the amount of the oil agent. .

本発明シートは、容器から積層シートを取り出し、発泡ゲル層又は発泡液層側を皮膚に貼付することにより簡便に使用できる。   The sheet of the present invention can be conveniently used by taking out the laminated sheet from the container and sticking the foamed gel layer or foamed liquid layer side to the skin.

実施例で使用した各種の測定方法を以下に示す。   Various measurement methods used in Examples are shown below.

(1)ゲルシート中二酸化炭素濃度測定方法:
二酸化炭素電極(電極model 9502 BN; Thermo Orion社及びポータブルpH/イオンメーターmodel 290A; ORION社)を用いて測定した。測定したいゲルシートをアルカリ溶液の入った蓋付き瓶に移動し、そのサンプルシートのゲルを溶解させた後、酸性緩衝液(pH4.5)で酸性に戻し発生する二酸化炭素を上記の電極を用いて測定した。
(1) Method for measuring carbon dioxide concentration in gel sheet:
Measurements were made using a carbon dioxide electrode (electrode model 9502 BN; Thermo Orion and portable pH / ion meter model 290A; ORION). The gel sheet to be measured is moved to a bottle with a lid containing an alkaline solution, the gel of the sample sheet is dissolved, and then the carbon dioxide generated by returning to acidity with an acidic buffer solution (pH 4.5) is generated using the above electrode. It was measured.

(2)皮膚血流量測定方法:
25℃の恒温室にて、30分間順化した後、前腕部の血流をドップラー血流計(BIOMEDICAL SCIENCE Co.,LTD LASER FLOWMETER KB−201)によって30秒測定し、その値の平均値を100として、同部位に各シートを貼付し保持時間後、シートを剥しその部位の血流量を測定し、相対値として表した。
(2) Skin blood flow measurement method:
After acclimatization for 30 minutes in a constant temperature room at 25 ° C., the blood flow in the forearm is measured for 30 seconds with a Doppler blood flow meter (BIOMDICAL SCIENCE Co., LTD LASER FLOWMETER KB-201), and the average value of the values is calculated. As 100, each sheet was affixed to the same part, and after the holding time, the sheet was peeled off, and the blood flow volume at the part was measured and expressed as a relative value.

(3)ピロー内空隙部酸素濃度測定方法:
1)50mLの目盛り付き注射筒に注射針を装着し、100%窒素ガスで満たしたアルミピローから、40mL分を注射筒に吸入した。
2)さらに、サンプルの入ったアルミピローから10mL分を追加吸入した。
3)注射針を取り外してすばやくパラフィルムで吸入口を塞いだ。
4)1分経過後、測定器(食品用微量酸素分析計IS−300 飯島電子工業(株))のサンプリング注射針をパラフィルム部分に突き刺し、酸素濃度測定をおこなった。
サンプル空隙部の酸素濃度は、簡易的に以下の式に従い算出した。
(3) Method for measuring void oxygen concentration in pillow:
1) A syringe was attached to a 50 mL graduated syringe, and 40 mL was sucked into the syringe from an aluminum pillow filled with 100% nitrogen gas.
2) Further, an additional 10 mL was inhaled from the aluminum pillow containing the sample.
3) The injection needle was removed and the inlet was quickly closed with parafilm.
4) After 1 minute, the sampling needle of a measuring device (micro oxygen analyzer for food IS-300 Iijima Electronics Co., Ltd.) was pierced into the parafilm part, and the oxygen concentration was measured.
The oxygen concentration in the sample void was simply calculated according to the following formula.

(数4)
空隙部酸素濃度(%)=測定値(%)×5
なお、空隙部二酸化炭素濃度は、前出の簡易的な計算によって算出した。
(Equation 4)
Void oxygen concentration (%) = measured value (%) × 5
The void portion carbon dioxide concentration was calculated by the simple calculation described above.

(4)皮下酸素分圧測定方法:
測定器として経皮血液ガスモニタPO−850A(新生電子(株)製)を用い、簡易的に以下の方法により測定をおこなった。
まず、コントロールとして、ピロー内空隙を酸素置換していない、空気のままで保持していたシートを前腕内側部の皮膚に5分適用した。シート適用除去後すばやくシート適用部の水分をティッシュでふき取り、測定器のセンサーを加温しないで、直ちにシート適用部分の皮膚に装着させた。装着直後より2分後までは10秒ごとに酸素分圧測定値を読み取り、以後10分後までは30秒ごとに酸素分圧測定値を読み取った。酸素分圧測定値をセンサー装着後の時間に対してグラフにプロットし、装着直後付近の測定値の並びに接するように直線を引き、直線の傾き、すなわち、皮膚表面酸素分圧低下速度を求めた。また、測定後半部10分付近でほぼ一定となった値を、コントロールの皮下酸素分圧とした。なお、コントロールの皮下酸素分圧はいずれもほぼ10mmHgであった。サンプルシート適用時もコントロールと同様にして測定した。皮膚表面酸素分圧低下速度が、外気酸素分圧(160mmHg)と皮下酸素分圧との差に比例すると仮定し、以下の式に従い、サンプルシート適用時の皮下酸素分圧を求めた。
サンプルシート適用時の皮下酸素分圧(mmHg)=160mmHg−(サンプルシート適用時の皮膚表面酸素分圧低下速度/コントロールの皮膚表面酸素分圧低下速度)×(160mmHg−10mmHg)
(4) Subcutaneous oxygen partial pressure measurement method:
Using a transcutaneous blood gas monitor PO-850A (manufactured by Shinsei Electronics Co., Ltd.) as a measuring device, the measurement was simply performed by the following method.
First, as a control, a sheet in which air in the pillow was not replaced with oxygen and was kept as air was applied to the skin on the inner side of the forearm for 5 minutes. Immediately after removing the sheet, the sheet application part was wiped with a tissue and immediately attached to the skin of the sheet application part without heating the sensor of the measuring instrument. The oxygen partial pressure measurement value was read every 10 seconds until 2 minutes after the attachment, and the oxygen partial pressure measurement value was read every 30 seconds until 10 minutes thereafter. Oxygen partial pressure measurement values were plotted on a graph against the time after wearing the sensor, a straight line was drawn so that the measured values immediately after wearing the sensor were in contact with each other, and the slope of the straight line, that is, the rate of decrease in skin surface oxygen partial pressure was obtained. . In addition, a value that became almost constant in the vicinity of 10 minutes in the latter half of the measurement was defined as the subcutaneous oxygen partial pressure of control. The subcutaneous oxygen partial pressure of the control was almost 10 mmHg. The measurement was performed in the same manner as the control when the sample sheet was applied. Assuming that the skin surface oxygen partial pressure reduction rate is proportional to the difference between the external oxygen partial pressure (160 mmHg) and the subcutaneous oxygen partial pressure, the subcutaneous oxygen partial pressure when applying the sample sheet was determined according to the following equation.
Subcutaneous oxygen partial pressure (mmHg) at the time of application of the sample sheet = 160 mmHg− (Skin surface oxygen partial pressure decrease rate at the time of sample sheet application / control skin surface oxygen partial pressure decrease rate) × (160 mmHg−10 mmHg)

<含気泡シートの調製>
(1)含気泡ゲルシートA
不織布(レーヨン:アクリル:PE=50:25:25;坪量35g/m2;厚さ0.1mm)上に、フィルム厚15μmとなるようにLDPE樹脂を210℃にて単層でTダイ押出しして積層シートを調製した(フィルムの二酸化炭素透過性12000cc/m2・day・atm)。
表1ゲル処方のメタケイ酸アルミン酸マグネシウム以外の成分を混合し攪拌具としてホイッパーを装着した万能混合攪拌機((株)ダルトン製)で7分間攪拌させた。気泡率は26.7%であった。メタケイ酸アルミン酸マグネシウムを加え、さらに30秒間ホイッパーで攪拌させた。得られた含気泡ゲルの気泡率は30.3%であった。含気泡ゲルを積層シートの不織布面にのせ、さらに50μmPETフィルムでカバーしてから、バーコーターを用いて厚みが1mmとなるように伸展して、2日間室温で放置して架橋ゲル化させ、フィルム付き含気泡ゲルシートAを調製した(皮膚貼付時は片側のPETフィルムをはがして、はがしたゲル面を皮膚に貼付)。なお、フィルムと発泡ゲル層の界面において、フィルムに積層した不織布が発泡ゲル層の一部へ入り込むことでアンカー効果を示し、フィルムと発泡ゲル層は強固に接着されていた。
<Preparation of a bubble-containing sheet>
(1) Air-containing gel sheet A
On a non-woven fabric (rayon: acrylic: PE = 50: 25: 25; basis weight 35 g / m 2 ; thickness 0.1 mm), LDPE resin was extruded as a single layer at 210 ° C. in a single layer so as to have a film thickness of 15 μm. Thus, a laminated sheet was prepared (carbon dioxide permeability of film: 12,000 cc / m 2 · day · atm).
Components other than the magnesium metasilicate aluminate in Table 1 gel formulation were mixed and stirred for 7 minutes with a universal mixing stirrer (manufactured by Dalton Co., Ltd.) equipped with a whipper as a stirring tool. The bubble rate was 26.7%. Magnesium aluminate metasilicate was added and further stirred with a whipper for 30 seconds. The cell content of the obtained cell-containing gel was 30.3%. A foam-containing gel is placed on the nonwoven fabric surface of the laminated sheet, and further covered with a 50 μm PET film, and then stretched to a thickness of 1 mm using a bar coater and left at room temperature for 2 days to form a cross-linked gel. A bubble-containing gel sheet A was prepared (at the time of skin application, the PET film on one side was peeled off, and the peeled gel surface was applied to the skin). In addition, in the interface of a film and a foaming gel layer, the nonwoven fabric laminated | stacked on the film showed an anchor effect because it entered into a part of foaming gel layer, and the film and the foaming gel layer were adhere | attached firmly.

Figure 2010202609
Figure 2010202609

(2)含気泡ゲルシートB
また、同じ含気泡ゲルを50μmPETフィルム2枚の間にはさみ、バーコーターを用いて厚みが1mmとなるように伸展して、2日間室温で放置して架橋ゲル化させ、フィルム無し含気泡ゲルシートBを調製した(皮膚貼付時は両側のPETフィルムをはがして、いずれか一方の面を皮膚に貼付)。
(2) Air-containing gel sheet B
In addition, the same cell-containing gel is sandwiched between two 50 μm PET films, stretched to a thickness of 1 mm using a bar coater, and allowed to crosslink and gel at room temperature for 2 days. (At the time of skin application, the PET film on both sides was peeled off, and either side was applied to the skin).

(3)含気泡ゲルシートC
表1ゲル処方のメタケイ酸アルミン酸マグネシウム以外の成分を混合し攪拌具としてフックを装着した万能混合攪拌機((株)ダルトン社製)に入れ、真空ポンプで−0.09MPaに減圧して7分間攪拌させた。攪拌を止めてから徐々に常圧に戻した。メタケイ酸アルミン酸マグネシウムを加え、軽くかき混ぜてから再び真空ポンプで−0.09MPaに減圧して、さらに30秒間攪拌させた。攪拌を止めてから徐々に常圧に戻した。得られたゲルの気泡率は0.8%であった。ゲルを積層シートの不織布面にのせ、さらに50μmPETフィルムでカバーしてから、バーコーターを用いて厚みが0.7mmとなるように伸展して、2日間室温で放置して架橋ゲル化させ、フィルム付き含気泡ゲルシートB(比較ゲルシート)を調製した(皮膚貼付時は片側のPETフィルムをはがして、はがしたゲル面を皮膚に貼付)。
(3) Cell-containing gel sheet C
Table 1 Components other than magnesium aluminate metasilicate of gel formulation were mixed and put into a universal mixing stirrer (manufactured by Dalton Co., Ltd.) equipped with a hook as a stirring tool, and reduced to -0.09 MPa with a vacuum pump for 7 minutes. Stir. After the stirring was stopped, the pressure was gradually returned to normal pressure. Magnesium aluminate metasilicate was added, and the mixture was lightly stirred, and then the pressure was reduced again to -0.09 MPa with a vacuum pump, and the mixture was further stirred for 30 seconds. After the stirring was stopped, the pressure was gradually returned to normal pressure. The resulting gel had an air bubble ratio of 0.8%. The gel is placed on the nonwoven fabric surface of the laminated sheet, covered with a 50 μm PET film, stretched to a thickness of 0.7 mm using a bar coater, and left at room temperature for 2 days to form a cross-linked gel. A bubble-containing gel sheet B (comparative gel sheet) was prepared (at the time of skin application, the PET film on one side was peeled off and the peeled gel surface was applied to the skin).

実施例1
厚み1mmのフィルム付き含気泡シートAを70mm×50mmに切り出し、アルミピローに100%二酸化炭素とともに封入させてインパルスシーラーで閉じ、さらに室温で7日間放置して、容器入りサンプルシートAを調製した。サンプルシート1枚の重量は2.5gであった。サンプルシートAの入ったアルミピロー中の空隙部二酸化炭素濃度を測定した後にアルミピローを開封し、片側のPETフィルムをはがして、開封直後のゲル中の二酸化炭素濃度を測定した。全部で3サンプル分の測定をおこない各二酸化炭素濃度の平均値を求めた。
また、サンプルシートAの入ったアルミピローを開封し、片側のPETフィルムをはがして、はがしたゲル面が肌側になるように前腕内側部の皮膚上に置き、10分間保持させた。シート除去後の皮膚の皮膚紅潮を目視確認するとともに皮膚血流およびゲルシート中の二酸化炭素濃度を測定した。なお、皮膚紅潮は、貼付部と未貼付部との境界の明確さを以下の5段階で評価した。
5:境界がはっきりしている
4:境界がややはっきりしている
3:境界がわずかに認識できる
2:境界がぼんやりしている
1:まったく境界が認められない
測定パネル3名について1回ずつ試験をおこない皮膚紅潮および二酸化炭素濃度の平均値を求めた。結果を表2に示した。
Example 1
A bubble-containing sheet A with a film having a thickness of 1 mm was cut into a size of 70 mm × 50 mm, sealed with 100% carbon dioxide in an aluminum pillow, closed with an impulse sealer, and allowed to stand at room temperature for 7 days to prepare a sample sheet A in a container. The weight of one sample sheet was 2.5 g. After measuring the void portion carbon dioxide concentration in the aluminum pillow containing the sample sheet A, the aluminum pillow was opened, the PET film on one side was peeled off, and the carbon dioxide concentration in the gel immediately after opening was measured. A total of 3 samples were measured and the average value of each carbon dioxide concentration was determined.
Moreover, the aluminum pillow containing the sample sheet A was opened, the PET film on one side was peeled off, placed on the skin on the inner side of the forearm so that the peeled gel surface was on the skin side, and held for 10 minutes. The skin flushing of the skin after the sheet removal was visually confirmed, and the skin blood flow and the carbon dioxide concentration in the gel sheet were measured. For skin flushing, the clarity of the boundary between the applied part and the non-applied part was evaluated in the following five levels.
5: The boundary is clear 4: The boundary is slightly clear 3: The boundary is slightly recognizable 2: The boundary is blurred 1: The test is performed once for three measurement panels in which no boundary is recognized at all The average value of skin flush and carbon dioxide concentration was determined. The results are shown in Table 2.

厚み1mmのフィルム無し含気泡ゲルシートBを用いたほかは実施例1と同様にして容器入りサンプルシートBを調製し、同様の試験をおこなった。なお、サンプルシート1枚の重さは2.5gであり、皮膚貼付時は両面のPETフィルムを除去して試験をおこなった。結果を表2に示した。   A sample sheet B containing a container was prepared in the same manner as in Example 1 except that the film-free cell-containing gel sheet B having a thickness of 1 mm was used, and the same test was performed. The weight of one sample sheet was 2.5 g, and the test was conducted by removing the PET film on both sides when applying the skin. The results are shown in Table 2.

厚み0.7mmのフィルム付き含気泡ゲルシートCを用いたほかは実施例1と同様にして容器入りサンプルシートCを調製し、同様の試験をおこなった。なおサンプルシート1枚の重さは2.5gであった。結果を表2に示した。   A sample sheet C with a container was prepared in the same manner as in Example 1 except that the air-containing gel sheet C with a film having a thickness of 0.7 mm was used, and the same test was performed. The weight of one sample sheet was 2.5 g. The results are shown in Table 2.

Figure 2010202609
Figure 2010202609

本発明のサンプルシートA(ゲルの気泡率30.3%)は、皮膚10分貼付後でも二酸化炭素濃度1000ppm以上の高濃度を保持しており、十分な血流促進効果が認められた。一方、重量およびゲルの気泡率がサンプルシートAと同じであっても、フィルムのついていないサンプルシートBでは、二酸化炭素濃度が100ppm以下に低下し、血流促進は認められなかった。また、サンプルシートAと同様にフィルム付で同じゲル重量で気泡率が少ない(気泡率0.8%)サンプルシートCは、皮膚10分貼付で二酸化炭素濃度が500ppm以下に低下しており、また血流促進効果が十分でなかった。   Sample sheet A of the present invention (gel bubble ratio of 30.3%) retained a high carbon dioxide concentration of 1000 ppm or more even after 10 minutes of skin application, and a sufficient blood flow promoting effect was observed. On the other hand, even if the weight and the bubble ratio of the gel were the same as those of the sample sheet A, in the sample sheet B without the film, the carbon dioxide concentration was reduced to 100 ppm or less, and blood flow promotion was not recognized. Similarly to sample sheet A, sample sheet C with a film with the same gel weight and low bubble rate (bubble rate 0.8%) has a carbon dioxide concentration of 500 ppm or less after 10 minutes of skin application. The blood flow promoting effect was not sufficient.

<含気泡シートの調製>
(1)含気泡ゲルシートD
不織布(レーヨン:アクリル:PE=50:25:25;坪量35g/m2;厚さ0.1mm)上に、フィルム厚15μmとなるようにEVOH樹脂を250℃にて単層でTダイ押出しして積層シートを調製した(フィルムの酸素透過性10cc/m2・day・atm)。EVOH積層シートを用いてシートの厚みを1.4mmとしたほかは、LDPEを積層させた含気泡ゲルシートAの調製と同様にして、含気泡ゲルシートDを調製した。
<Preparation of a bubble-containing sheet>
(1) Cell-containing gel sheet D
On a non-woven fabric (rayon: acrylic: PE = 50: 25: 25; basis weight 35 g / m 2 ; thickness 0.1 mm), EVOH resin is extruded as a single layer at 250 ° C. in a single layer so as to have a film thickness of 15 μm. Thus, a laminated sheet was prepared (film oxygen permeability of 10 cc / m 2 · day · atm). A bubble-containing gel sheet D was prepared in the same manner as the preparation of the bubble-containing gel sheet A laminated with LDPE except that the thickness of the sheet was 1.4 mm using an EVOH laminate sheet.

(2)含気泡ゲルシートE、Fの調製
EVOH積層シートを用いてシートの厚みを1.4mmとしたほかは、LDPEを積層させたフィルム付き含気泡ゲルシートCの調製と同様にして、フィルム付き含気泡ゲルシートEを調製した。また、シート厚みを1mmとしてフィルム付き含気泡ゲルシートFを調製した。
(2) Preparation of cell-containing gel sheets E and F Except that the thickness of the sheet was 1.4 mm using an EVOH laminated sheet, the film-containing gel sheet C was prepared in the same manner as the cell-containing cell-containing gel sheet C laminated with LDPE. A foam gel sheet E was prepared. In addition, an air-containing gel sheet F with a film having a sheet thickness of 1 mm was prepared.

実施例2
厚み1.4mmのフィルム付き含気泡シートDを図1の形状に切り出し、アルミピローに100%酸素とともに封入させてインパルスシーラーで閉じ、さらに室温で7日間放置して、サンプルシートDを調製した。サンプルシートD1枚の重量は3.0gであった。
また、皮下酸素分圧測定用のコントロールとして、ガス置換をおこなわないでアルミピロー内に封入したコントロールシートも同時に調製した。
サンプルシートのアルミピロー内空隙部の酸素濃度を測定した。全部で3サンプル分の測定をおこない酸素濃度の平均値を求めた。
Example 2
A film-containing bubble-containing sheet D having a thickness of 1.4 mm was cut into the shape shown in FIG. 1, sealed in an aluminum pillow with 100% oxygen, closed with an impulse sealer, and further allowed to stand at room temperature for 7 days to prepare a sample sheet D. The weight of one sample sheet D was 3.0 g.
In addition, as a control for measuring the subcutaneous oxygen partial pressure, a control sheet enclosed in an aluminum pillow without gas replacement was also prepared at the same time.
The oxygen concentration in the voids in the aluminum pillow of the sample sheet was measured. A total of three samples were measured to obtain an average value of oxygen concentration.

アルミピローを開封し、片側のPETフィルムをはがして、はがしたゲル面が肌側になるように前腕内側部に貼付し、20分間保持させた。シート除去後の皮膚の白抜けを目視確認するとともに、皮下酸素分圧を測定した。皮膚の白抜けは、貼付部と未貼付部との境界の明確さを実施例1と同様の5段階基準で評価した。   The aluminum pillow was opened, the PET film on one side was peeled off, applied to the inner side of the forearm so that the peeled gel surface was on the skin side, and held for 20 minutes. While visually checking the white spots of the skin after the sheet was removed, the subcutaneous oxygen partial pressure was measured. As for the white spots on the skin, the clarity of the boundary between the applied part and the non-applied part was evaluated based on the same five-step criteria as in Example 1.

一方で、フェイスでのフィット感の評価もおこなった。アルミピローを開封し、サンプルシートの片側のPETフィルムをはがして、はがしたゲル面が肌側になるように目の下側の皮膚に貼付し、20分間保持させた。貼付中のフィット感を、はがれ感なし:4、少しはがれ感あり:3、はがれ感あり:2、はがれおちる:1、として4段階で評価した。
測定パネル3名についてそれぞれ1回ずつ試験をおこない皮膚白抜けおよび皮下酸素分圧、フィット感の平均値を求めた。結果を表3に示した。
On the other hand, the fit on the face was also evaluated. The aluminum pillow was opened, the PET film on one side of the sample sheet was peeled off, applied to the skin under the eyes so that the peeled gel surface was on the skin side, and held for 20 minutes. The fit during application was evaluated on a four-point scale, with no peeling feeling: 4, with some peeling feeling: 3, with peeling feeling: 2, and peeling off: 1.
The test was performed once for each of the three measurement panels, and the average values of skin whitening, subcutaneous oxygen partial pressure, and fit were obtained. The results are shown in Table 3.

厚み1.4mmのフィルム付き含気泡ゲルシートEを用いて実施例2と同様にサンプルシートE、また厚み1mmのフィルム付き含気泡ゲルシートFを用いてサンプルシートFを調製し、同様の試験をおこなった。なお、サンプルシートE1枚の重量は4.3g、サンプルシートF1枚の重量は3.0gであった。結果を表3に示した。   A sample sheet E was prepared in the same manner as in Example 2 using an air-containing gel sheet E with a film having a thickness of 1.4 mm, and a sample sheet F was prepared using an air-containing gel sheet F with a film having a thickness of 1 mm, and the same test was performed. . The weight of one sample sheet E was 4.3 g, and the weight of one sample sheet F was 3.0 g. The results are shown in Table 3.

Figure 2010202609
Figure 2010202609

EVOHフィルム付き、気泡率30.3%、厚み1.4mmのサンプルシートDは、皮下に酸素が浸透して白抜けが認められ肌へのフィット感も良かった。一方、発泡ゲル層の気泡率0.8%のサンプルシートEは、サンプルシートDより重くてフィット感が悪く、皮下酸素分圧も低く白抜けの程度も低かった。また、厚みを1mmにしたサンプルシートFは、サンプルシートDと同程度の重さのため肌へのフィット感は良かったが、気泡率が0.8%と低いため、皮下酸素分圧は低く白抜けの程度も低かった。   Sample sheet D with an EVOH film, a bubble rate of 30.3%, and a thickness of 1.4 mm had a good fit to the skin because oxygen penetrated subcutaneously and white spots were observed. On the other hand, the sample sheet E having a foam ratio of 0.8% in the foamed gel layer was heavier than the sample sheet D and had a poor fit, and the subcutaneous oxygen partial pressure was low and the degree of white spots was low. In addition, the sample sheet F having a thickness of 1 mm has a good fit to the skin because of the same weight as the sample sheet D. However, since the bubble ratio is as low as 0.8%, the subcutaneous oxygen partial pressure is low. The degree of white spots was also low.

Claims (7)

気泡率5〜50%の気泡を含有する発泡ゲル層又は発泡液層と樹脂フィルムとの積層シートを気体難透過性容器内に密封してなり、保存時の容器中の空隙部に身体に対して生理活性のある気体を30質量%以上含有する容器入り身体貼付用シート。   A layered sheet of foamed gel layer or foamed liquid layer containing bubbles with a cell rate of 5 to 50% and a resin film is hermetically sealed in a gas-impermeable container. A body-attaching sheet containing 30% by mass or more of a physiologically active gas. 身体に対して生理活性のある気体が、酸素又は二酸化炭素である請求項1記載のシート。   The sheet according to claim 1, wherein the gas having physiological activity on the body is oxygen or carbon dioxide. 保存時の容器内部の気圧が、0.05〜0.15MPaである請求項1又は2に記載のシート。   The sheet according to claim 1 or 2, wherein the pressure inside the container during storage is 0.05 to 0.15 MPa. 樹脂フィルムの気体透過率が、20,000cc/m2・day・atm以下である請求項1〜3のいずれか1項記載のシート。 The sheet according to any one of claims 1 to 3, wherein the gas permeability of the resin film is 20,000 cc / m 2 · day · atm or less. 発泡ゲル層が、アニオン性ポリマーと多価陽イオンにより形成された発泡水性ゲル層である請求項1〜4のいずれか1項記載のシート。   The sheet according to any one of claims 1 to 4, wherein the foamed gel layer is a foamed aqueous gel layer formed of an anionic polymer and a polyvalent cation. 発泡ゲル層又は発泡液層が、油分を含有する請求項1〜5のいずれか1項記載のシート。   The sheet according to any one of claims 1 to 5, wherein the foamed gel layer or the foamed liquid layer contains an oil component. 気体難透過性容器内に、気泡率5〜50%の気泡を含有する発泡ゲル層又は発泡液層と樹脂フィルムとが積層されたシートを入れ、次いで容器中の空隙部に身体に対して生理活性のある気体を30質量%以上になるように充填した後、容器を密封する、容器入り身体貼付用シートの製造法。   A sheet in which a foamed gel layer or a foamed liquid layer containing bubbles with a bubble rate of 5 to 50% and a resin film are laminated is placed in a gas-impermeable container, and then the body is physiologically placed in the void in the container. A method for producing a body-applied sheet containing a container, wherein an active gas is filled to 30% by mass or more and then the container is sealed.
JP2009051784A 2009-03-05 2009-03-05 Body sticker sheet in a container Active JP5396105B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009051784A JP5396105B2 (en) 2009-03-05 2009-03-05 Body sticker sheet in a container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009051784A JP5396105B2 (en) 2009-03-05 2009-03-05 Body sticker sheet in a container

Publications (2)

Publication Number Publication Date
JP2010202609A true JP2010202609A (en) 2010-09-16
JP5396105B2 JP5396105B2 (en) 2014-01-22

Family

ID=42964463

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009051784A Active JP5396105B2 (en) 2009-03-05 2009-03-05 Body sticker sheet in a container

Country Status (1)

Country Link
JP (1) JP5396105B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012140373A (en) * 2010-12-28 2012-07-26 Kao Corp Oxygen feed sheet
JP2016505542A (en) * 2012-12-03 2016-02-25 アヴェント インコーポレイテッド Lotion tablet supplying oxygen
WO2018181930A1 (en) * 2017-03-31 2018-10-04 積水化成品工業株式会社 Gel sheet
KR20200036138A (en) * 2018-09-27 2020-04-07 한국생산기술연구원 Method for preparing multilayered polymeric sheet capable of degassing comprising foamed polymeric layer
WO2020071186A1 (en) 2018-10-05 2020-04-09 花王株式会社 Adhesive sheet for affixation to body, housed in container
JP2021165252A (en) * 2020-04-07 2021-10-14 花王株式会社 Production method of carbon dioxide gas-including hydrous gel article
US12029754B2 (en) 2018-10-05 2024-07-09 Kao Corporation Adhesive sheet for affixation to body, housed in container

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005170937A (en) * 2003-11-21 2005-06-30 Kao Corp Sticking sheet material for body
JP2008050316A (en) * 2006-08-25 2008-03-06 Kao Corp Skin preparation for external use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005170937A (en) * 2003-11-21 2005-06-30 Kao Corp Sticking sheet material for body
JP2008050316A (en) * 2006-08-25 2008-03-06 Kao Corp Skin preparation for external use

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012140373A (en) * 2010-12-28 2012-07-26 Kao Corp Oxygen feed sheet
JP2016505542A (en) * 2012-12-03 2016-02-25 アヴェント インコーポレイテッド Lotion tablet supplying oxygen
EP3603608A4 (en) * 2017-03-31 2021-01-13 Sekisui Plastics Co., Ltd. Gel sheet
WO2018181930A1 (en) * 2017-03-31 2018-10-04 積水化成品工業株式会社 Gel sheet
CN110430859A (en) * 2017-03-31 2019-11-08 积水化成品工业株式会社 Gel film
JPWO2018181930A1 (en) * 2017-03-31 2019-12-26 積水化成品工業株式会社 Gel sheet
CN110430859B (en) * 2017-03-31 2022-09-30 积水化成品工业株式会社 Gel sheet
KR20200036138A (en) * 2018-09-27 2020-04-07 한국생산기술연구원 Method for preparing multilayered polymeric sheet capable of degassing comprising foamed polymeric layer
KR102132345B1 (en) * 2018-09-27 2020-07-10 한국생산기술연구원 Method for preparing multilayered polymeric sheet capable of degassing comprising foamed polymeric layer
KR20210027453A (en) 2018-10-05 2021-03-10 카오카부시키가이샤 Self-adhesive adhesive sheet in container
JP2020059697A (en) * 2018-10-05 2020-04-16 花王株式会社 Adhesive sheet for affixation to body housed in container
CN112789049A (en) * 2018-10-05 2021-05-11 花王株式会社 Adhesive sheet for body attachment in container
WO2020071186A1 (en) 2018-10-05 2020-04-09 花王株式会社 Adhesive sheet for affixation to body, housed in container
KR102542692B1 (en) * 2018-10-05 2023-06-13 카오카부시키가이샤 Adhesive sheet for attaching to the body in a container
TWI825181B (en) * 2018-10-05 2023-12-11 日商花王股份有限公司 Adhesive sheet for body attachment in container
JP7421296B2 (en) 2018-10-05 2024-01-24 花王株式会社 Adhesive sheet for body application in container
US12029754B2 (en) 2018-10-05 2024-07-09 Kao Corporation Adhesive sheet for affixation to body, housed in container
JP2021165252A (en) * 2020-04-07 2021-10-14 花王株式会社 Production method of carbon dioxide gas-including hydrous gel article
WO2021205719A1 (en) * 2020-04-07 2021-10-14 花王株式会社 Method for producing carbon dioxide-containing hydrogel article
CN115335026A (en) * 2020-04-07 2022-11-11 花王株式会社 Method for producing water-containing gel article containing carbonic acid gas

Also Published As

Publication number Publication date
JP5396105B2 (en) 2014-01-22

Similar Documents

Publication Publication Date Title
JP5396105B2 (en) Body sticker sheet in a container
JP4088298B2 (en) Body affixing sheet
JP5226948B2 (en) Laminated sheet and body sticking sheet
US20220387673A1 (en) Hydrophilic medical products and hydration mediums for hydrating the same
JP4658568B2 (en) Body sheet material
JP4684992B2 (en) Equipment for storing and dispensing gas-dissolved products
WO2011013619A1 (en) Functional sheet
JP5031135B2 (en) Steam generator
JP6486773B2 (en) Gel external composition containing adenine compound
TWI825181B (en) Adhesive sheet for body attachment in container
JP2006089459A (en) Sheet-like composition
GB9818115D0 (en) Applying fluid preparation to the skin e g in connection with shaving
JP3668161B2 (en) Method for producing carbonic acid transdermal composition
JP5647764B2 (en) Oxygen supply sheet for body attachment in a container
JP4629983B2 (en) Carbon dioxide supply bag
CN115737674A (en) Oxygen-containing preparation for treating acne and wound surface, preparation method and application device thereof
US20200085706A1 (en) Skin improving kit and face pack
JP5738588B2 (en) Oxygen supply sheet
EP4054662B1 (en) Hydrophilic medical products and hydration mediums for hydrating the same
JP4719441B2 (en) Sheet preparation for body patch
US12029754B2 (en) Adhesive sheet for affixation to body, housed in container
JP6481175B2 (en) Carbonate sheet mask
TWI293031B (en) Composition for percutaneous absortion of carbon dioxide
BR112020002524A2 (en) cosmetic infused with therapeutic gas and infusion methods

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130618

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130806

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20131015

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131021

R151 Written notification of patent or utility model registration

Ref document number: 5396105

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250